Differential expression of CD44S and hyaluronic acid in malignant mesotheliomas, adenocarcinomas, and reactive mesothelial hyperplasias

Applied Immunohistochemistry

Volumn 6, Issue 1, 1998, Pages 11-15

  Afify, Alaa M ^a   Stern, Robert ^b   Jobes, Greg ^a   Bailey, Joyce L ^a   Werness, Bruce A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenocarcinoma; CD44S; Hyaluronic acid; Malignant mesothelioma; Mesothelial hyperplasia

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID;

ADENOCARCINOMA; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; HYPERPLASIA; MALIGNANT MESOTHELIOMA; METASTASIS; PRIORITY JOURNAL;

EID: 0031918009     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-199803000-00003     Document Type: Article

References (21)

1. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-57.
2. Guan JL, Chen HC. Signal transduction in cell-matrix interactions. Int Rev Cytol 1996;168:81-121.
3. Underhill C. CD44: the hyaluronan receptor. J Cell Sci 1992;103: 293-8.
4. Prieto VG, Reed JA, McNutt S, Bogdany JK, Lugo J, Shea CR. Differential expression of CD44 in malignant epithelial neoplasms. Am J Dermatopathol 1995;17:447-51.
5. Wielenga VJ, Heider KH, Offerhaus GJ, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754-6.
6. Rall CJN, Rustig AK. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Cancer Res 1995;55: 1831-5.
7. Hofmann M, Rudy W, Zoller M, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991;51:5292-7.
8. Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
9. Lewin DL. New reports blur image of a promising metastasis marker. J Natl Cancer Inst 1996:8:24-6.
10. Knudson W, Biswas C, Li X-Q, Nemec RE, Toole BP. The role and regulation of tumour-associated hyaluronan. Ciba Found Symp 1989; 143: 150-69.
11. Battifora H, McCaughey WTE. Tumors of the serosal membranes, vol. 15. Washington, DC: Armed Forces Institute of Pathology, 1995.
12. Goshen R, Ariel I, Shuster S, et al. Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis. Mol Hum Reprod 1996;2:685-91.
13. Laurent T, Fraser JRE. Hyaluronan. FASEB J 1992;6:2397-404.
14. Thomas L, Byers R, Vink J, Stamenkovic I. CD44H regulates tumor cell migration of hyaluronate-coated substrate. J Cell Biol 1992;18:971-7.
15. Horai T, Nakamura N, Tateishi R, Hattori S. Glycosaminoglycans in human lung cancer. Cancer 1981;48:2016-21.
16. Toole BP, Biswas C, Gross J. Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci USA 1979;76:6299-303.
17. Zhang L, Underhill CB, Chen L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 1995;55:428-33.
18. Attanoos RL, Webb R, Gibbs AR. CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma. Histopathology 1997;30:260-3.
19. Azumi N, Underhill CB, Kagan E, Sheibani K. A novel biotinylated probe specific for hyaluronate: its diagnostic value in diffuse malignant mesothelioma. Am J Surg Pathol 1992;16:116-21.
20. Sheibani K, Esteban JM, Bailey A, Battifora H, Weiss LM. Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol 1992;23:107-16.
21. Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology 1997;30:403-18.